Breast cancer treatment andprevention may benefit from future studies of PPARγ therapy that address issues of susceptiblebreast cancer subtypes, duration and timing of intervention in the multistepprocess of mammary carcinogenesis. The gene discussed is PPARG; the disease is breast carcinoma.